Clinical Trial Data Aggregation Architecture

Decentralized Clinical Trial Aggregation & 21 CFR Part 11 Bio-Repository Platform

A global contract research organization faced fragmented trial data across 45 international study sites, paper-driven subject diaries, and critical compliance risks during FDA inspection audits.
Codixon engineered a unified, multi-tenant electronic data capture (EDC) and bio-repository data aggregation platform featuring cryptographic audit logging, automated sensor normalization, and real-time query resolution, cutting study closeout cycles by 46%.
Discuss Life Sciences Architecture Explore Life Sciences Solutions
Executive Impact

Key Clinical Research Outcomes

Measurable acceleration across trial monitoring velocity, data compliance integrity, and cross-site study closeouts.

46 %
Faster Study Closeout Automated data lock and discrepancy resolution
100 %
Audit Readiness Strict FDA 21 CFR Part 11 and GCP regulatory compliance
82 %
Query Resolution Speed Real-time automated field validation at capture point
45 +
Sites Harmonized Unified bio-repository and clinical telemetry streams
Technical Constraints

Multi-Site Clinical Trial Friction

Decentralized trial models exposed deep data fragmentation, slow patient compliance reporting, and labor-intensive monitoring reconciliations.

Fragmented Multi-Site Silos

Data Silos

Disparate investigative sites maintained isolated electronic case report forms (eCRFs) and local bio-specimen tracking sheets without central synchronization.

Regulatory Audit Vulnerabilities

Compliance Risk

Legacy systems lacked cryptographic attribution, immutable timestamping, and electronic signatures required under FDA 21 CFR Part 11 mandates.

High Subject Drop-Out Rates

Subject Attrition

Complex paper journals and clunky patient-reported outcome (ePRO) forms led to incomplete patient logs and delayed safety alerts.

Protracted Database Lock Cycles

Study Latency

Reconciling conflicting laboratory bio-sample reports with clinical observations took months of manual query generation by clinical monitors.

Engineering Blueprint

Unified EDC & Bio-Repository Pipeline Architecture

A tamper-evident, multi-tenant cloud data fabric harmonizing clinical endpoints, specimen custody, and telemetry streams.

01
CAPTURE

Unified Multi-Modal EDC & ePRO Ingestion

Constructed responsive mobile and web capture interfaces with offline sync capabilities, streaming encrypted patient-reported outcomes directly into study pipelines.

02
VALIDATION

Real-Time Algorithmic Edit Checks

Implemented automated validation microservices executing instant protocol range checks, flagging anomalies and firing queries before investigators leave the encounter view.

03
GOVERNANCE

21 CFR Part 11 Cryptographic Audit Trail

Engineered append-only write audit logs with dual-factor e-signatures and immutable SHA-256 state hashing to satisfy global health authority inspection standards.

04
BIO-TRACKING

Specimen Custody & Bio-Repository Linking

Coupled barcode specimen accessioning with cold-chain sensor data, linking biological sample vials deterministically to clinical trial subject timelines.

Technology Matrix

Clinical SaaS Production Stack

Zero-trust, GxP-validated cloud architecture engineered for multi-tenant scalability and data integrity.

Core Application & APIs
.NET 9 / C#
Go
gRPC / Protobuf
Clinical Data & Streaming
PostgreSQL
Redis
Apache Kafka
Frontend & Mobile
React
TypeScript
Docker Containers
Infrastructure & Audit
Kubernetes (K8s)
Amazon Web Services
OpenTelemetry
Verified Business Impact

Accelerated Regulatory Filings, Absolute Data Verifiability

"Codixon delivered a modern EDC and bio-repository platform that resolved our international study bottlenecks. We unified 45 clinical sites under a single compliant pipeline, slashed query turnaround, and sailed through FDA inspections without a single 483 observation."
D
Dr. Claire Hemmings
Head of Global Clinical Data Operations , Global Contract Research Organization
Key Business Results

Measurable Organizational Impact

  • Accelerated overall clinical trial database lock and study closeout timelines by 46%.
  • Lowered manual data query resolution intervals from 14 business days to under 48 hours.
  • Achieved 100% compliance passing FDA 21 CFR Part 11 and EMA GCP validation audits.
  • Reduced patient compliance dropout by 31% via frictionless mobile-first ePRO diaries.
Life Sciences Architecture Strategy

Architect Your Next-Generation Clinical Trial Platform

Collaborate with dedicated enterprise software engineers to deploy compliant EDC pipelines, bio-repository tracking, and real-time trial monitoring systems.

Discuss Life Sciences Architecture Schedule Consultation
  • Strict 21 CFR Part 11, HIPAA, and GCP compliant design patterns
  • Scalable multi-tenant trial architecture with role-based access control
  • Complete source code, validation documentation, and infrastructure ownership